Results 31 to 40 of about 305,776 (256)

Plasma Concentrations of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor in Lymphoproliferative Disorders [PDF]

Acta Medica (Hradec Kralove, Czech Republic), 2005
Angiogenesis plays a major role in the development and progression of haematological malignancies. In our study we measured plasma concentrations of key angiogenic activators vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) using comercially available sandwich enzyme-linked immunosorbent assay (ELISA) in 37 patients ...
Lukás, Smolej, Ctirad, Andrýs, Vladimír, Maisnar, Ludĕk, Pour, Jaroslav, Malý   +4 more
openaire   +3 more sources

Evaluation of antibacterial effect of concentrated growth factor on Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis

Journal of Family Medicine and Primary Care, 2022
Introduction: Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis are the two main bacteria that cause periodontitis which is an inflammatory disease of periodontal tissues.
Ramtin Chitsazha, Masoumeh Faramarzi, Mehrnoosh Sadighi, Reza Pourabbas, Maryam Pourhajibagher, Negin Firouzi, Mohammad Ghasemirad   +6 more
doaj   +1 more source

The Concentration of Epidermal Growth Factor in Japanese Mother's Milk.

Journal of Nutritional Science and Vitaminology, 1995
The concentration of epidermal growth factor (EGF) in human milk was measured by radioreceptor assay (RRA). Human milk samples collected from healthy Japanese mothers who delivered at full term were divided into 30 groups according to differences in the duration of lactation, seasons of the year and place of residence.
MATSUOKA, Yasuhiro, IDOTA, Tadashi
openaire   +3 more sources

Vascular endothelial growth factor and placenta growth factor concentrations in Down's syndrome and control pregnancies [PDF]

Molecular Human Reproduction, 2001
Vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) are considered to play important roles in angiogenesis and vascular permeability during placental development. Since trisomy 21 placentae show trophoblastic hypoplasia and hypovascularity, we investigated PLGF and VEGF synthesis in Down's syndrome pregnancies.
F, Debieve, A, Moiset, K, Thomas, S, Pampfer, C, Hubinont   +4 more
openaire   +2 more sources

Concentrated growth factors (CGF): morphological and biochemical characterization

Italian Journal of Anatomy and Embryology, 2015
Concentrated growth factors (CGF) represents the novel generation of solid plate- let concentrate preparations (1-2). These 100% autologous preparations, obtained from a venous blood sample, not only enhance tissue healing but also improve the clinical outcomes of various surgical procedures, reducing complications like pain, inflammation and morbidity
Bonazza, V, Dellavia, C, Labanca, M, Merigo, D, BORSANI, Elisa   +4 more
openaire   +2 more sources

Concentrated Growth Factor Promotes Wound Healing Potential of HaCaT Cells by Activating the RAS Signaling Pathway

Frontiers in Bioscience-Landmark, 2022
Objective: The aim of this study was to explore the effect of concentrated growth factor (CGF) on the wound healing potential of human epidermal cells (HaCaT) in vitro and in vivo.
Yueming Liu, Yang Liu, Changchun Zeng, Weishan Li, Changneng Ke, Shi Xu   +5 more
doaj   +1 more source

ROLE OF GROWTH HORMONE ON PLASMA EPIDERMAL GROWTH FACTOR CONCENTRATIONS [PDF]

Pediatric Research, 1987
Epidermal growth factor (EGF) is known to accelerate proliferation and differentiation of multiple cell types. We previously reported that growth hormone deficient (GHD) children have decreased urinary EGF excretion compared to normal children and the excretion of EGF increases with growth hormone (GH) administration.
Joseph P Frindik, Stephen F Kemp, M Joycelyn Elders   +2 more
openaire   +1 more source

Diş Hekimliğinde Trombosit Konsantrasyonlarinin Tarihsel Gelişimi ve Özellikleri

Cumhuriyet Dental Journal, 2018
Trombositler hemostaz ve yara iyileşmesinde çok önemli bir rol oynamakta ve ihtiva ettikleri büyüme faktörleri ve sitokinler sayesinde rejeneratif tedavinin potansiyel hücreleri arasında yer almaktadırlar.
Mehmet Kızıltoprak, Mustafa özay Uslu
doaj   +1 more source

Sixty-Month Follow Up of Clinical MRONJ Cases Treated with CGF and Piezosurgery

Bioengineering, 2023
Aims: Medication-related osteonecrosis of the jaw (MRONJ) is a drug-related adverse reaction characterized by bone destruction and necrosis in the jaw. This case series aims to evaluate the treatment approaches and outcomes in MRONJ patients.
Gianna Dipalma, Angelo Michele Inchingolo, Giuseppina Malcangi, Irene Ferrara, Fabio Viapiano, Anna Netti, Assunta Patano, Ciro Gargiulo Isacco, Alessio Danilo Inchingolo, Francesco Inchingolo   +9 more
doaj   +1 more source

Combined Surgical and Concentrated Growth Factor Therapy in the Management of Stage II and III MRONJ Associated with Denosumab: A Report of Two Cases

Türk Osteoporoz Dergisi
Medication-related osteonecrosis of the jaw (MRONJ) is a significant complication associated with antiresorptive agents such as denosumab, particularly in oncology patients.
Mert Kırdemir, Muharrem Ergün Dudak, Burak Borlu   +2 more
doaj   +1 more source